HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

Viatris Puts OTC Business Up For Sale

Viatris has decided to exit the consumer health market and has put up for sale an OTC business which is thought to generate around $1.0bn in annual sales.

Business Strategies Health

Haleon Establishing Own Distribution In India To Unleash Growth

Haleon is taking back full control of its interests in India by terminating a distribution deal for its OTC and oral care brands signed with Hindustan Unilever in 2020.

Business Strategies India

Alfasigma Signals Consumer Health Ambitions With Sofar Acquisition

By acquiring fellow Italian manufacturer Sofar, Alfasigma expands its consumer health footprint and adds products and expertise in its priority gastrointestinal category.

Deals Business Strategies
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

Nestlé Discovers Gut Bacteria Strain Suggesting Opportunities For Infant Nutrition

Scientists at Nestlé’s research division think that they have found new bifidobacterium longum strains that have unique ability to utilize both key components of human milk and fibers from solid food, opening up new opportunities for “next generation nutritional solutions” like probiotics targeting the crucial weaning period of child development.

International Wellness
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

Germany's PharmaSGP Raises Sales Guidance In 'Record Year'

European Consumer health player PharmaSGP is well on the way to achieving new record revenues in 2022, and is working to maintain this upward trajectory over the medium and long term. 

Europe Health

Taisho Boosted By Overseas Sales With Japanese Business Flat

Taisho's Self-Medication business posted a solid gain in the six months ended 30 September as a recovery in its Overseas operation boosted a flat performance in Japan.

Japan Europe

Haleon Raises Sales Guidance But Warns Of Tougher Q4

While Haleon expects 2022 sales to grow by around 8%, the UK-based consumer health giant faces a more difficult end to the year as it begins to cycle over significant price increases rolled out towards the end of 2021.

Sales & Earnings OTC Drugs
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Europe Germany

‘General Benefit’ Insufficient For EU Food For Special Medical Purposes Classification

In a case that could have far-reaching implications for the region's food supplement manufacturers, the European Court of Justice has ruled that the definition of foods for special medical purposes should be restricted to use in addressing a specific nutrient deficiency related to an illness, as defined by EU law.

Europe Germany

Ginkgo Biloba Extract Is Drug, Not Supplement, Rules German Supreme Court

Products containing “monograph compliant” ginkgo biloba dry extract as the main active ingredient at recommended doses of 100mg per day should be considered drugs, not dietary supplements, Germany’s federal administrative court has ruled. The decision settles a longstanding dispute between the country’s food regulator and an unnamed company that had applied for registration of such a product.

Germany Wellness
See All
UsernamePublicRestriction

Register